MS&AD Insurance Group (8725) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Jun, 2025Executive summary
Net premiums written rose 10.5% year-over-year to ¥3,571.2bn, driven by strong growth in overseas subsidiaries and domestic non-life insurance.
Net income attributable to owners of the parent surged 122.3% year-over-year to ¥626.1bn, achieving 99.4% of the revised annual forecast.
Ordinary profit more than doubled to ¥824.9bn, up 113.4% year-over-year, due to increased investment gains and reduced expenses.
Group adjusted profit increased by ¥366.5bn to ¥633.9bn, with a 94.6% progress rate on the annual target.
Total assets decreased by ¥450.3bn to ¥26,509.9bn, mainly from lower cash and securities balances.
Financial highlights
Domestic non-life net income rose by ¥321.3bn, supported by higher investment profits and lower catastrophe losses.
Overseas subsidiaries' net income increased by 45.8% to ¥127.9bn, with notable gains in Lloyd's, reinsurance, and Americas segments.
Investment income jumped 30.3% year-over-year to ¥1,159.5bn, with gains on sales of securities up 233.4%.
Life insurance premiums dropped 47% year-over-year to ¥380.3bn, reflecting a shift in product mix.
EPS (basic) for the period was ¥400.16, more than double the prior year, adjusted for a 3-for-1 stock split.
Outlook and guidance
FY2024 consolidated net income forecast revised upward by ¥20bn to ¥630.0bn, up 70.6% from the previous year.
Group adjusted profit forecast raised by ¥40bn to ¥670.0bn, reflecting favorable trends across all segments.
Ordinary profit for the year ending March 31, 2025, is projected at ¥893.0bn, up 114.4% year-over-year.
Dividend forecast for FY2025 is ¥145.00 per share, including special dividends.
Non-life net premiums written forecast raised to ¥4,630.0bn; overseas to ¥1,500.0bn.
Latest events from MS&AD Insurance Group
- Premiums, income, and solvency rose; major merger and strong non-life growth announced.8725
Q3 202613 Feb 2026 - Profit growth, Barings LLC investment, and higher capital returns marked the period.8725
Q2 202619 Nov 2025 - Net income rose 9.1% to 222.7 billion yen, led by strong non-life and overseas premium growth.8725
Q1 20268 Aug 2025 - Net income soared 424.5% on investment gains and lower losses, with forecasts and dividends raised.8725
Q2 202513 Jun 2025 - Net income and ordinary profit soared, led by overseas and investment gains.8725
Q1 202513 Jun 2025 - Record profit achieved, but next year's earnings are forecast to decline amid market risks.8725
Q4 20256 Jun 2025